| Dr Jordon Scott Folkers, DC | |
|
508 N 6th St, Seward, NE 68434-1706 | |
| (402) 646-2020 | |
| Not Available |
| Full Name | Dr Jordon Scott Folkers |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 12 Years |
| Location | 508 N 6th St, Seward, Nebraska |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720333206 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1725 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hackbart Chiropractic Pc | 9436229481 | 2 |
News Archive
ImmunoCellular Therapeutics today announced that it has entered into an agreement with the University of Pennsylvania under which University of Pennsylvania has granted the Company an exclusive, worldwide license for a patent pending technology for the production of high-activity dendritic cells.
The Washington Post: "The agreement for Baltimore-based Johns Hopkins Health System to acquire Sibley Memorial Hospital is likely to be approved by District officials as soon as Thursday, giving the world-class academic medical center its first foothold in the District. Driven by Sibley's need to ensure long-term financial stability by increasing its volume of patients, the move will allow Hopkins to improve its market position in the Washington-Baltimore region.
ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.
InspireMD, Inc., a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, announced positive clinical results from an investigator-sponsored controlled randomized trial conducted in Chile.
Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa, which is home to the largest underserved patient population in the world.
› Verified 3 days ago
| Provider Name | Hackbart Chiropractic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1467672865 PECOS PAC ID: 9436229481 Enrollment ID: O20080602000826 |
News Archive
ImmunoCellular Therapeutics today announced that it has entered into an agreement with the University of Pennsylvania under which University of Pennsylvania has granted the Company an exclusive, worldwide license for a patent pending technology for the production of high-activity dendritic cells.
The Washington Post: "The agreement for Baltimore-based Johns Hopkins Health System to acquire Sibley Memorial Hospital is likely to be approved by District officials as soon as Thursday, giving the world-class academic medical center its first foothold in the District. Driven by Sibley's need to ensure long-term financial stability by increasing its volume of patients, the move will allow Hopkins to improve its market position in the Washington-Baltimore region.
ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.
InspireMD, Inc., a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, announced positive clinical results from an investigator-sponsored controlled randomized trial conducted in Chile.
Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa, which is home to the largest underserved patient population in the world.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jordon Scott Folkers, DC 508 N 6th St, Seward, NE 68434-1706 Ph: (402) 646-2020 | Dr Jordon Scott Folkers, DC 508 N 6th St, Seward, NE 68434-1706 Ph: (402) 646-2020 |
News Archive
ImmunoCellular Therapeutics today announced that it has entered into an agreement with the University of Pennsylvania under which University of Pennsylvania has granted the Company an exclusive, worldwide license for a patent pending technology for the production of high-activity dendritic cells.
The Washington Post: "The agreement for Baltimore-based Johns Hopkins Health System to acquire Sibley Memorial Hospital is likely to be approved by District officials as soon as Thursday, giving the world-class academic medical center its first foothold in the District. Driven by Sibley's need to ensure long-term financial stability by increasing its volume of patients, the move will allow Hopkins to improve its market position in the Washington-Baltimore region.
ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.
InspireMD, Inc., a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, announced positive clinical results from an investigator-sponsored controlled randomized trial conducted in Chile.
Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa, which is home to the largest underserved patient population in the world.
› Verified 3 days ago
Dylan Miller, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 729 Seward St Ste 4, Seward, NE 68434 Phone: 402-643-3696 | |
Dr. Richard F Soucek, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 729 Seward St, Suite 4, Seward, NE 68434 Phone: 402-643-3696 Fax: 402-643-4392 | |
Dr. Shawn Allen Svoboda, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 306 S. 4th Street, Suite 200, Seward, NE 68434 Phone: 402-643-4244 Fax: 402-643-4255 | |
Tyler Hackbart, Chiropractor Medicare: Medicare Enrolled Practice Location: 508 N 6th St, Seward, NE 68434 Phone: 402-646-2020 Fax: 402-646-2029 | |
Bell Chiropractic, P.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 905 Main St, Seward, NE 68434 Phone: 785-627-8434 | |
Jordan Lawrence Bell, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 905 Main St, Seward, NE 68434 Phone: 785-627-8434 | |
Seward Chiropractic Center, P.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 729 Seward St, Suite 4, Seward, NE 68434 Phone: 402-643-3696 Fax: 402-643-4392 |